LRRK2 and progressive supranuclear palsy: For example, LRRK2 p.N2081D has been implicated as a shared risk variant in Crohn's disease,8 and independent LRRK2 5' variation has been shown to be a modifier of progressive supranuclear palsy phenotypes.32